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Abstract
Background: In Zanzibar, the Ministry of Health and partners accelerated malaria control from September 2003
onwards. The impact of the scale-up of insecticide-treated nets (ITN), indoor-residual spraying (IRS) and artemisinin-
combination therapy (ACT) combined on malaria burden was assessed at six out of seven in-patient health
facilities.
Methods: Numbers of outpatient and inpatient cases and deaths were compared between 2008 and the pre-
intervention period 1999-2003. Reductions were estimated by segmented log-linear regression, adjusting the effect
size for time trends during the pre-intervention period.
Results: In 2008, for all age groups combined, malaria deaths had fallen by an estimated 90% (95% confidence
interval 55-98%)(p < 0.025), malaria in-patient cases by 78% (48-90%), and parasitologically-confirmed malaria out-
patient cases by 99.5% (92-99.9%). Anaemia in-patient cases decreased by 87% (57-96%); anaemia deaths and out-
patient cases declined without reaching statistical significance due to small numbers. Reductions were similar for
children under-five and older ages. Among under-fives, the proportion of all-cause deaths due to malaria fell from
46% in 1999-2003 to 12% in 2008 (p < 0.01) and that for anaemia from 26% to 4% (p < 0.01). Cases and deaths
due to other causes fluctuated or increased over 1999-2008, without consistent difference in the trend before and
after 2003.
Conclusions: Scaling-up effective malaria interventions reduced malaria-related burden at health facilities by over
75% within 5 years. In high-malaria settings, intensified malaria control can substantially contribute to reaching the
Millennium Development Goal 4 target of reducing under-five mortality by two-thirds between 1990 and 2015.
Background
Before scale-up of malaria control activities in 2004-2005,
malaria was the leading cause of illness and death in Zan-
zibar, accounting for more than 50% of in-patient cases
and deaths in hospitals and nearly 40% of all out-patient
consultations. Endemicity was classified as moderate to
high, with transmission occurring for more than 6 months
per year [1,2]. In 2003, malaria prevalence in sampled 60
clusters of Shehia (the smallest administrative unit with
estimated population of 3,000) ranged between 9% and
50% in children under five years of age and other age
groups, with Plasmodium falciparum the predominant
malaria species [2]. In the year 2000, chloroquine, the
first-line drug then, had a treatment failure of 60% at
14 days follow up [3].
Between end-2003 to 2006, in response to the enor-
mous malaria burden and to the inadequacy of chloro-
quine treatment, the Zanzibar Ministry of Health and
Social Welfare and partners initiated a concerted effort
to accelerate malaria control activities. With support of
the Global Fund to Fight AIDS, Tuberculosis and
Malaria (starting in 2005), the USA President’s Malaria
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Initiative, the Italian Cooperation through WHO,
and other partners, the government scaled up four
key malaria control interventions: deployment of
artemisinin-based combination therapy (ACT), distribu-
tion of insecticide-treated nets (ITNs), including long-
lasting insecticidal nets (LLINs), indoor residual spraying
(IRS) and intermittent preventive treatment with sulpha-
doxine-pyrimethamine for pregnant women (SP-IPTp).
In September 2003, artemether-lumefantrine was
introduced in all public health facilities, free-of-charge,
as the first-line treatment for uncomplicated malaria,
regardless of age (Zanzibar Ministry of Health and
Social Welfare, unpublished report, 2002), while
SP-IPTp was initiated in 2004. From 2004, ITNs were
distributed for free, to pregnant women and children
under five years of age attending antenatal clinics in
public health facilities; LLINs followed by mid-2005. IRS
with lambdacyhalothrin was implemented since June-
July 2006, covering nearly all households (one round in
2006, two rounds in 2007 and one round in 2008), with
the exception of the main town’s centre. In May 2007,
74% children under-5 and 73% pregnant women used
an ITN. In addition, nearly 95% of houses had been
sprayed with an insecticide during the previous six
months [4].
This study reports on the impact of the interventions’
scale up in six out of seven Zanzibar’s in-patient health
facilities, based on analysis of time trends in malaria-
related and overall child and adult morbidity and
mortality over a 10-year period (1999-2008). Results are
discussed in light of international goals and targets for
reducing malaria and improving child health at a popu-
lation level.
Methods
Sample of hospitals
Out of Zanzibar’s 126 total health facilities, seven are in-
patient facilities; this analysis covers six of them: Chake-
chake, Mkoani and Wete district hospitals; and the
three large primary health care centres with in-patient
services (Kivunge and Makunduchi on Unguja island,
and Micheweni centre on Pemba island). Zanzibar’s
main referral hospital was excluded because surveillance
data for the past years were not available.
Indicators
Monthly records of outpatient cases, inpatient cases and
inpatient deaths, stratified by age <5 years old and ≥5
years old, were coded according to recorded diagnosis,
i.e. malaria, anaemia and ‘other conditions’.
Inpatient malaria cases and deaths include those that
were parasitologically-confirmed and those admitted
based on clinical judgement. For malaria outpatient
cases, analyses were done both for cases with a
confirmed parasitological diagnosis and for the total
number of cases, including those diagnosed presump-
tively. To facilitate interpretation of trends in outpatient
cases, we computed slide positivity rate, by dividing the
number of slides positive for malaria by the total num-
ber of slides examined.
Cases and deaths attributed to anaemia, to which
malaria is an important contributor in high-endemic set-
tings [5], were analyzed as a proxy indicator of malaria-
related burden.
Possible confounding of the interventions’ effect by
external, non-program related determinants was
explored by analysing the time trend in monthly rainfall
and temperature, the principal short-term predictor of
malaria transmission intensity and burden [6].
Statistical analysis of time trends
Impact was evaluated by comparing 2008 indicators
with those in the pre-intervention period 1999–2003
using a segmented regressive model of an interrupted
time series [7]. Impact is defined as the ratio between
the observed and a counterfactual estimated indicator
levels in 2008, the latter calculated assuming a (hypothe-
tical) continuation of the pre-intervention time trend
throughout 2008, thereby adjusting for time trends
occurring independent of the intervention’s effect. The
95% confidence intervals (CI) around impact estimates
were computed based on CIs around regression coeffi-
cient estimates.
Changes over time in proportions of cases or deaths
due to malaria or other causes were evaluated by
Chi-squared test. The exact Fisher test was used where
the chi-squared test was not suitable due to small num-
bers, i.e. where the expected value in any of the cells of
a contingency table was below 5.
Results
Malaria in-patient cases were fairly stable between 1999
and 2002 but declined gradually thereafter, both among
children under-5 (Figure 1a) and in the older age group
(Figure 1b). A similar decline was seen for anaemia
cases, although among children under-five this decline
started already around the year 2000. In contrast, hospi-
talizations due to other causes tended to increase
throughout the evaluation period. This resulted in a
stable number of total hospitalizations in the older age
group (Figure 1d). Among children under-five, the num-
ber of hospitalizations decreased, while the percentage
of malaria cases decreased from 54% in 1999 to 17% in
2008 (Figure 1c).
Hospital deaths showed similar time patterns across
causes for both age groups (Figure 2a and 2b). Among
under-fives, among all-cause deaths, the proportion due
to malaria fell from 46% in 1999 to 12% in 2008 (p <
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Figure 1 In-patient cases due to malaria, anaemia and other causes in children under 5 years and >5 years old, 6 hospitals in
Zanzibar.
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0.01)(Figure 2c) and that due to anaemia from 26% to
4% (p < 0.01). Similarly, in the older age group the pro-
portion of malaria deaths decreased from 52% in 1999
to 4% in 2008 (p < 0.01)(Figure 2d) and that due to
anaemia from 8% to 4% (p < 0.05). Deaths due to other
causes did not change or rather increased, with no con-
sistent difference in the time trend before and after
2003.
Within each of the six individual health facilities, simi-
lar declines were observed in the number of malaria in-
patient cases (Figure 3a), although the onset of malaria-
related reductions varied among facilities. In Chakechake
hospital, malaria in-patient cases peaked in 2004 and
then decreased 3-fold by 2007–2008 as compared to the
1999 level. Kivunge and Makunduchi showed similar but
lower peaks in 2004 with subsequent declines to below
the 1999 level. In the other 3 health facilities, no major
peaks were observed: malaria cases were stable initially,
declining from 2003 onwards in Wete and Micheweni,
and declining throughout the 10-year period in Mkoani.
Malaria deaths also declined in each of the individual
hospital, starting in 2002–2003 and reaching numbers
well below the 1999 levels by 2008 (Figure 3b).
Malaria out-patient cases totalled 24,000 in 1999,
among children under-5, out of which 9,000 were
microscopically confirmed (Figure 4a). These numbers
declined from 2003 onwards, reaching 5,000 total cases
of which only 31 were confirmed in 2008. The decline
was more marked for confirmed cases and this was par-
alleled by a similar decrease in the slide positivity rate
(Figure 4c). Numbers of slides examined also fell, in line
with the number of suspected cases; both of these indi-
cators decreasing around three-fold between 1999 and
2008 (Figure 4d). A similar pattern was observed for the
0 
40 
80 
120 
160 
200 
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
in
-p
a
ti
e
n
t 
m
a
la
ri
a
 c
a
s
e
s
, 
(s
ta
n
d
a
rd
iz
e
d
 t
o
 
1
9
9
9
) 
Chakechake Kivunge 
Makunduchi Micheweni 
Mkoani  Wete 
0 
100 
200 
300 
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 
in
-p
a
ti
e
n
t 
m
a
la
ri
a
 d
e
a
th
s
, 
(s
ta
n
d
a
rd
iz
e
d
 t
o
 
1
9
9
9
) 
Chakechake Kivunge 
Makunduchi Micheweni 
Mkoani  Wete 
Figure 3 In-patient (a) cases and (b) deaths due to malaria, children under-5 years, in individual hospitals.
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older age group (Figure 4b). The number of inpatient
anaemia cases declined in a similar manner, with about
a 2-fold decrease by 2008 compared to 1999-2001 levels.
Adjusting for pre-intervention time trends, malaria-
attributed in-patient and out-patient cases and deaths
decreased by 76% or more by 2008 compared to 1999-
2003, both age groups (Table 1; p < 0.025 for each indi-
cator). In-patient anaemia cases decreased by 85% and
90% among under-fives and over-fives, respectively (p <
0.025), with non-significant decrease for anaemia deaths
(by 38% in under-fives and 66% for older ages). In con-
trast, no difference (and sometimes an increase) was
observed in the number of cases and deaths due to
other causes, without any consistent difference in time
trends before and after 2003 (Table 1).
Rainfall peaked in March–May and October–Novem-
ber (Figure 5). Malaria and anaemia inpatient cases var-
ied seasonally with yearly peaks in May-June and
November-December. From 2006 onwards, as malaria
and anaemia cases decreased, the seasonal peaks in
these hospital indicators became less pronounced.
Discussion
This rapid impact evaluation shows that scale-up of
ACT as first-line treatment of malaria, combined with
vector control using ITNs/LLINs and IRS resulted a
dramatic decline in the malaria burden. Within four
years of intervention scale-up, malaria deaths, hospitali-
zations, laboratory-confirmed outpatient cases and slide
positivity rates fell by 76% or more, both in children
under-5 years and older age groups.
Unconfirmed (suspected) outpatient cases and num-
bers of slides examined also fell, but to a lesser extent
(two- to three-fold), and starting later than laboratory-
confirmed indicators. This suggests that the decline in
confirmed malaria cases reflect a real reduction in
malaria-attributable burden, and not an artefact related
to changing laboratory testing patterns. The lesser
decline in suspected malaria cases compared to parasito-
logically-confirmed cases or malaria hospitalizations and
deaths confirms the notion that in endemic settings a
large proportion of suspected cases is not due to malaria.
This supports the WHO’s 2010 recommendation for
parasitological confirmation using either microscopy or
RDT of all cases as a condition for ACT-based treatment,
including in children under-five years in high-endemic
Africa for whom presumptive treatment was recom-
mended until 2010 - in an effort to contain costs of
ACT-based treatment and to preserve ACT efficacy [8].
Hospitalizations and deaths due to anaemia fell in par-
allel with the malaria-attributed events, confirming the
importance of malaria as an underlying cause, especially
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Figure 4 Out-patient cases due to malaria, anaemia and other causes, (a) children under-5 and (b) older ages; (c) malaria slide
positivity rates and (d) numbers of slides examined for malaria, 6 hospitals in Zanzibar.
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Table 1 Malaria and non-malaria cases and deaths in 2008 compared to the pre-intervention period 1999–2003, in six
out of seven hospitals in Zanzibar
MALARIA ANAEMIA
Age (years) Average 1999-2003 2008 % decline (95 CI) Average 1999-2003 2008 % decline (95 CI)
In-patient cases <5 5,166 861 80 (44 - 93)‡ 728 51 85 (39 - 97)‡
5+ 4,376 1,017 76 (33 - 91)‡ 298 29 90 (38 - 98)‡
All 9,542 1,878 78 (48 - 90)‡ 1,026 80 87 (57 - 96)‡
Out-patient cases (confirmed) <5 8,637 31 99.6 (93 - 99.98)‡ 804 347 45 (-60 - 81)
5+ 8,738 36 99 (91 - 99.97)‡ 840 588 -40 (-355 - 57)
All 17,375 67 99.5 (92 - 99.97)‡ 1,644 935 9 (-87 - 56)
Deaths <5 227 23 86 (21 - 97)‡ 91 7 38 (-1’373 - 97)
5+ 137 6 95 (30 - 100)‡ 28 7 66 (-1’116 - 99)
All 365 29 90 (55 - 98)‡ 120 14 40 (-1’406 - 98)
OTHER All-CAUSE
Age (years) Average 1999-2003 2008 % decline (95 CI) Average 1999-2003 2008 % decline (95 CI)
In-patient cases <5 4,114 4,298 21 (-243 - 82) 10,008 5,210 46 (-37 - 79)
5+ 9,114 13,106 13 (-60 - 53) 13,788 14,152 25 (-35 - 59)
All 13,228 17,404 15 (-39 - 48) 23,796 19,362 32 (-16 - 60)
Out-patient cases <5 30,453 36,375 -19 (-82 - 23) 54,114 41,411 17 (-38 - 50)
5+ 37,514 63,621 -47 (-144 - 11) 59,943 69,131 -21 (-113 - 32)
All 67,968 99,996 -36 (-104 - 10) 114,057 110,542 -3 (-69 - 37)
Deaths <5 111 156 -121 (-1’011 - 56) 430 186 14 (-116 - 66)
5+ 106 180 -10 (-501 - 80) 271 193 37 (-44 - 72)
All 216 336 -53 (-531 - 63) 701 379 23 (-42 - 59)
Notes:
Positive values indicate a decline; negative percentages indicate an increase from 1999-2003 to 2008.
‡ Significant difference. A 95% CI not including the 0% value indicates that the difference from pre-intervention period to 2008 was statistically significant (p <
0.025).
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in children under-five years. These observations are con-
sistent with previous studies that showed steady reduc-
tions in childhood anaemia in response to malaria
control [5], and with observed correlation between rates
of malaria and of blood transfusions in young children
[9]. Anaemia represented a much larger proportion of
hospital deaths than hospital admissions, e.g. among
under-fives in 1999, 26% and 8.5%, respectively. This
difference illustrates the poor prognosis of severe anae-
mia cases in Zanzibar, which is possibly due to varying
availability and quality of blood transfusion services and
late presentation of patients [10,11].
The decline in malaria-related burden started around
2003, when ACT was introduced, although for in-
patient cases and deaths in children under five years it
started slightly earlier, around 2002, possibly reflecting
the increasing use, since 2001, of sulphadoxine-
pyrimethamine as second-line treatment. In addition,
ongoing socio-economic development and urbanization
may have led to a better health over time in including
malaria burden, before and during the intensified
malaria control [12]. However, impact estimates using
segmented log-linear regression (Table 1) were adjusted
for such trends during pre-intervention period and the
decrease in malaria was observed against an increase in
non-malaria attendances - which may be the result of
improved health services and access in recent years.
Across all 147 out-patient peripheral health facilities
in Zanzibar (primary health care units), confirmed
malaria cases fell by 73% between 1999 and 2008 while
the slide positivity rate fell from 36% to 1.5% (Zanzibar
Malaria Control Programme, unpublished, 2010). Over
the same period, the slide testing rate of all outpatient
consultancies in the peripheral facilities increased from
6% to 30% as a result of RDT roll-out.
In the weekly case-based surveillance system, which
covers approximately one-third of health facilities, slide
positivity rate was 3% in peak malaria months (April-
June) during 2008 [13]. Reductions in parasitologically-
confirmed malaria out-patient cases furthermore fit with
results from a nation-wide population survey in May
2007, showing parasite prevalence of 0.4% in children
<5 years old and 0.9% in all ages [4].
A 2007 study in North A district of Unguja using sur-
veillance records in 13 public health facilities found a
decline in under-five mortality by 52% in 2006 com-
pared to 2003. Similarly, malaria-related admissions,
blood transfusions, and malaria-attributed mortality
decreased significantly by 77%, 67% and 75%, respec-
tively, between 2002 and 2005 in children under five.
While climatic conditions favourable for malaria trans-
mission persisted throughout the observational period,
additional distribution of LLINs in early 2006 resulted
in a 10-fold reduction of malaria parasite prevalence
[14].
In response to its current low endemicity, Zanzibar
has since 2008 shifted its malaria surveillance system to
weekly reporting of laboratory-based confirmed malaria
cases. A Malaria Early Epidemic Detection System
(MEEDS) is now operational in 52 health facilities, with
the plan to expand it to all facilities by 2011. The next
step for enhancing disease surveillance should be report-
ing and investigation of individual in-patient cases and
deaths, which at low transmission levels represent a fail-
ure of the health system in adequately treating both
uncomplicated and severe malaria cases. Future report-
ing of individual case records will also enable more pre-
cise geographical tracking of remaining transmission
foci or “hotspots” and resurgences, as well as to identify
risk groups and factors.
Despite Zanzibar’s enormous success in reducing
malaria, the risk of an explosive resurgence is still very
real. This is not the first time that the islands have
achieved such dramatic decline in malaria burden. In
the 1970s malaria had been reduced to very low levels
through IRS with dichlorodiphenyltrichloroethane
(DDT), only to resurge again once partner funds
decreased and IRS was stopped [15]. Aggressive malaria
control activities and adequate funding therefore need
to be maintained to keep the risk of malaria resurgence
near to zero.
Substantial decreases in malaria burden have also been
reported by other high-endemic sub-Saharan African
countries that achieved high coverage of ACT, LLINs
and/or IRS. In Zambia, as artemether-lumefantrine was
introduced as first-line treatment, and LLINs were dis-
tributed over 2002-2008, hospital admissions and deaths,
and to a lesser extent outpatient cases from malaria and
anaemia, decreased substantially. Declines were more
marked in children under five than among older ages,
and time trends were consistent across the indicators.
Repeated household surveys demonstrated parallel
decreases in parasite prevalence and anaemia among
children under five years. In addition, among children
under five years, both all-cause mortality from house-
hold surveys and hospital-recorded deaths fell by half, in
a markedly similar time pattern [16]. Importantly, these
downward trends were followed by levelling off in 2009
in malaria admissions and deaths - including a major
resurgence in two provinces, where parasite prevalence
among children again rose according to a 2010 survey
[17,18]. This rebound, possibly related to decay of insec-
ticide and physical deterioration of ITNs distributed sev-
eral years before, underscores the importance also for
Zanzibar to maintain malaria control, surveillance and
funding to prevent similar resurgence.
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In Bioko Island, Equatorial Guinea, four years after
achieving high intervention coverage, repeated household
surveys found a decrease in all-cause under-five mortality
of 60% from 2004 to 2008, and reductions of 70% in
parasite prevalence, 90% in anaemia and 60% in reported
fevers among children under-5 [19]. In Rwanda, within
two years of nationwide implementation of LLIN distri-
bution and ACT as first-line treatment, in-patient
malaria cases and death in nine hospitals and 10 health
centers sampled throughout 10 districts fell by 55% and
67% in children under-five, respectively. Non-malaria
cases and deaths remained stable or increased [20]. Simi-
larly, in Ethiopia, in a convenience sample of public facil-
ities with relatively complete data, the in-patient case and
death burden decreased by 73% and 62%, respectively,
after the first two years of scaled-up LLIN and ACT
usage [20]. In Sao Tome and Principe, after three years of
intensified interventions with IRS, LLINs, ACT and SP-
IPTp, malaria-attributed outpatient consultations, hospi-
talizations, and deaths decreased by more than 85%, 80%,
and 95%, respectively, in all age groups [21]. In The
Gambia, a similar retrospective analysis at four sites,
showed between 2003 and 2007 a significant decline in
malaria slide positivity rate, malaria admissions and
malaria-related deaths. The same study also demon-
strated a significant increase in mean haemoglobin con-
centrations for all-cause admissions (12 g/l) and age of
paediatric malaria admissions (from 3.9 to 5.6 years) [9].
When interpreting the results presented, the limita-
tions of health facility-based studies should not be
underestimated [22]. Importantly, the use of a five-year
period (1999-2003) as reference was not necessarily long
enough to provide a stable pre-intervention baseline,
given the historical resurgence of malaria in Zanzibar in
the past [23]. In addition, a longer period should ideally
be used as the post-intervention. Therefore, point esti-
mates of impact based on a five-year baseline and one-
year post-intervention must, therefore, be regarded as
indicative, rather than precise effect sizes.
It should be also considered that time trends observed
in health facility statistics may not reflect trends in
malaria burden at the population level, if the complete-
ness of case or death notifications and/or access to
health facilities changes over the evaluation period, and
in particular if notification fraction changed differently
for malaria versus other causes of attendance. As a
result, the decrease in malaria burden may be of lesser
magnitude than that observed in the hospitals sampled.
Of note, the reduction in all-cause under-five mortality
may be lower at a population level than shown here
from hospitals data, because typically in sub-Saharan
African countries with stable malaria around 15-30% of
deaths, not 53% as in the Zanzibar hospitals between
1999 and 2003, are due to malaria [24].
The child survival Millennium Development Goal is to
reduce all-cause under-5 mortality by two-thirds by
2015 compared to 1990 baseline levels [25,26]. The new
Roll Back Malaria Partnership goal is the near elimina-
tion of malaria deaths by 2015 [27]. Based on mortality
estimates from 1990 to 2009, the under-5 mortality
rates are now declining in all regions of the world, with
declines in sub-Saharan Africa having accelerated in the
2000-2010 decade. However, a further acceleration in
these declines will be needed to meet the MDG child
survival goal [28].
Conclusion
Effective malaria control measures can dramatically
reduce the burden of malaria and anaemia on the health
system. Ensuing reductions in all-cause under-5 mortal-
ity as a result of malaria control could play a key role in
achieving MDG4 on improving child survival by 2015.
Aggressive malaria control should be raised to the high-
est levels of public health priority in Africa and globally.
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